跳至主要内容
临床试验/NCT05374200
NCT05374200已完成不适用

A Randomized Control Trial Evaluating the Impact of a 12-week Mind-body Wellness Intervention in Patients With Primary Biliary Cholangitis (PBC)

University of Alberta2 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2021年10月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
87
试验地点
2
主要终点
HADS Anxiety and Depression Scale

研究概览

简要总结

The investigators have designed a guided, online, multicomponent, mind-body intervention for participants with primary biliary cholangitis. The ability of the online intervention to impact the primary and secondary outcome measures will be assessed as compared to control.

详细描述

Persons with primary biliary cholangitis (PBC) experience significantly higher rates of fatigue, stress, anxiety, depression, and impaired health related quality of life (HRQOL) as compared to the general population. Online wellness programming ranging from physical activity to mindfulness interventions has been shown to be effective in decreasing fatigue and improving mental wellness in a variety of chronic disease populations. To date, no large-scale studies have been conducted to discern whether programming of this nature impacts measures of wellbeing in PBC.

Building upon a 12-week, online, mind-body wellness program that our team previously co-developed with the Canadian PBC Society and launched as a feasibility and acceptability trial to a group of 30 individuals with PBC, the primary aim of this research project is to carry out a randomized controlled trial to assess the efficacy of the online intervention provided with brief study follow-up phone calls performed weekly by study personnel as compared to a control arm. The ability of the online program to impact the primary outcome measure of anxiety and depression as measured by the hospital anxiety and depression scale (HADS), and a range of secondary outcomes including perceived stress, fatigue, resilience, health related quality of life, physical functioning will be assessed as compared to control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Sealed envelopes

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (≥ 18 years)
  • Identified diagnosis of PBC
  • Ability to communicate (read, write, speak) in English
  • Access to an internet connected device at home.

排除标准

  • Inability to provide informed consent
  • Unsafe to participate in a low-intensity online activity program (e.g. uncontrolled angina or arrhythmia, myocardial infarction or stroke within the last 3 month, other major medical comorbidity of concern)
  • Severe psychiatric disorders (HADS score >10)

结局指标

主要结局

HADS Anxiety and Depression Scale

时间窗: Baseline to 12 weeks

Depression and anxiety will be measured on the Hospital Anxiety and Depression Scale. The minimum score is 0, the maximum score is 21, and higher scores indicate a worse outcome.

次要结局

  • PBC-40(Baseline to 12 weeks)
  • Connor Davidson Resilience Scale 10(12 Weeks)
  • Perceived Stress Scale(12 Weeks)
  • Modified Fatigue Impact Scale(12 Weeks)
  • Lower Extremity Function Scale(12 Weeks)
  • Capability, Opportunity, Motivation, Behavior (COM-B) Survey(12 Weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验